Pharma — India Trademark Cases
454 decisions indexed
Page 6 of 16 · 454 total
Glaxo Group Limited v.Dermazone Pharmaceuticals Private Limited
Glaxo Group Limited successfully secured an ad-interim injunction against Dermazone Pharmaceuticals in a trademark infringement suit. The Delhi High Court found that the Defendant's mark, 'BECLOVATE,' is phonetically and deceptively similar to the Plaintiff's registered mark, 'BETNOVATE.' Given the identical nature of the products (skin treatments) and strong market presence of Glaxo, the court granted immediate relief to prevent consumer confusion. The injunction restricts the manufacture and sale of the infringing product moving forward.
Medybiz Pharma Pvt. Ltd. v.The Registrar of Trademarks
Medybiz Pharma Pvt. Ltd. filed a Civil Miscellaneous Appeal challenging the refusal of their trademark application by The Registrar of Trademarks. However, before the High Court could rule on the merits of the appeal, the appellant chose to withdraw the case. Consequently, the Madras High Court dismissed (T)CMA(TM).No.56 of 2023 as withdrawn without passing any order regarding costs.
Indoco Remedies Limited v.M/S.Micro Labs Ltd.
The Madras High Court disposed of a dispute between Indoco Remedies Limited and M/S.Micro Labs Ltd regarding the trade mark 'CITALIFT'. The parties reached an agreement, leading the court to mandate the cancellation of the disputed registration (No. 1005556). Micro Labs agreed to change its mark to 'MICROLIFT' while being granted a six-month grace period to liquidate existing inventory bearing the old mark.
M/s. TIL Healthcare Private Limited v.The Registrar of Trade Marks
The Madras High Court allowed the appeal filed by TIL Healthcare Private Limited, setting aside the Trade Mark Office's refusal to register the mark 'URELOG'. The court found that despite objections based on similarity to existing marks, the appellant successfully demonstrated the distinctiveness of the word mark. By considering the specific derivation of the elements ('URE' from urea/urine and 'LOG' from ketoanalogue) and noting that the mark was not a self-evident fusion, the High Court directed the Registrar to accept the application for advertisement.
Jupiter Drugs Partnership Concern v.Mrs.M.Sarojini Proprietrix; The Deputy Registrar of Trademarks
Jupiter Drugs filed an Original Petition seeking to expunge or limit the registered trademark 'ZIPROVIT' (No. 1306475) held by Mrs. M. Sarojini Proprietrix, citing issues related to geographical scope and use. However, the Madras High Court dismissed the petition for non-prosecution because the petitioner could not be served notice due to an outdated address. This procedural dismissal effectively halted Jupiter Drugs' attempt to challenge the trademark registration.
Glaxo Group Limited And Anr. v.Manoj Kumar Jain And Ors.
The Delhi High Court addressed a trademark infringement and passing off suit filed by Glaxo Group Limited against Manoj Kumar Jain and others. Although the matter was resolved amicably through a settlement, leading to the decreeing of specific terms, the court also independently declared the Plaintiffs' mark 'BETNESOL' as a well-known mark due to its long history and extensive market presence in the pharmaceutical sector. This judgment underscores the dual nature of IP disputes: resolution via negotiation alongside judicial recognition of brand status.
Dr. Reddys Laboratories Limited v.Fast Cure Pharma And Anr.
The Delhi High Court allowed a petition seeking the rectification of a trademark registration, declaring the mark 'RAZOFAST' illegal. The court found that 'RAZOFAST' was deceptively similar to the petitioner's prior registered mark 'RAZO', which is used for the pharmaceutical compound Rabeprazole. Consequently, the registration of 'RAZOFAST' was cancelled and removed from the register.
Dhanvantari Nano Ayushadi Private Limited v.The Registrar of Trade Marks
Dhanvantari Nano Ayushadi Private Limited filed a Civil Miscellaneous Appeal seeking to set aside an order passed by the Registrar of Trade Marks concerning the registration of the mark “NANO CUR”. The appeal was dismissed for non-prosecution because the appellant could not be served notice due to having vacated the specified office address.
Mankind Pharma Limited v.4 Square Pharmaceuticals Of ... and The Registrar of Trade Marks
The Madras High Court dismissed a petition filed by Mankind Pharma Limited seeking the removal of Trademark No. 1803072 (XYDI). The court noted that the last registration for this trademark had expired on April 6, 2019. Since the underlying issue—the status of the mark's validity—had changed, the petition was deemed infructuous. Mankind Pharma was granted leave to re-apply should the trademark be restored.
Perennial Health Care India Private Limited v.Manju Bai & Ramesh Kumar M.Jain; The Registrar of Trademarks
The Madras High Court case involving Perennial Health Care India Private Limited and Manju Bai & Ramesh Kumar M.Jain was concluded when the petitioner chose to withdraw their original petitions. The petitions, which sought various remedies under the Trademarks Act, 1999, including removal of specific trademark entries in Class 5, were formally dismissed as withdrawn by the court on August 23, 2023.
United Biotech Private Limited v.Sun Pharma Laboratories Limited
The Madras High Court allowed United Biotech Private Limited's petition seeking the removal of the trade mark 'ONCONASE' (No. 447044) registered in favour of Sun Pharma Laboratories Limited. The court found that the mark had not been used since its registration, thereby satisfying the grounds for cancellation under Section 47 of the Trade Marks Act, 1999. Consequently, the Registrar was directed to remove the entry from the Register within four weeks.
Pfizer Products Inc. v.R. Hanumantha Rao
Pfizer Products Inc. successfully petitioned the Madras High Court to expunge the registration of the trademark VECOREX (No. 980006) from the register. The court noted that the mark had not been renewed since December 29, 2020. Consequently, the court directed the Registrar of Trademarks to remove the entry within four weeks, effectively clearing the mark for potential use by the petitioner.
Mankind Pharma Limited v.Trivigya Bioscience
In a trademark dispute concerning the 'KIND' family of marks, Mankind Pharma Limited successfully secured an undertaking from Trivigya Bioscience. The respondent acknowledged the propriety of Mankind's marks and voluntarily agreed to cease using the contested mark CDKIND in relation to pharmaceutical preparations. Consequently, the rectification application was disposed of as not pressed, resolving the conflict amicably.
Mankind Pharma Limited v.Genova Biotechniques Pvt. Ltd.
Mankind Pharma Limited successfully petitioned the Madras High Court to remove a specific trademark, 'PSO KIND,' from the register. The court observed that while the mark was initially registered, its renewal had lapsed after November 8, 2020. Consequently, the time limit for both renewal and restoration had expired. The court directed the Registrar of Trademarks to cancel the registration certificate and remove the entry within four weeks.
M/s. Wockhardt Limited v.Apex Laboratories Limited
The Madras High Court addressed an appeal challenging a trademark registration refusal. The appellant argued that the lower court's review was improperly exercised as an appeal, citing strict limitations on review jurisdiction. However, the Court found that the original decision failed to address key submissions made by the respondent regarding prior use and lack of evidence from the appellant. Consequently, the Court held that these omissions constituted 'errors apparent on the face of the record,' allowing the review order to stand.
Mankind Pharma Limited v.Neospark Drugs And Chemicals Private Limited; The Registrar of Trade Marks
The Madras High Court ruled in favor of Mankind Pharma Limited, directing the removal of the trademark MAXCAL GEL (No. 2102511) from the Trade Marks Register. The court found that the registration had lapsed and was not renewed within the statutory time limits. This decision underscores the strict adherence required to maintain trademark rights through timely renewal procedures.
Sun Pharma Laboratories Ltd v.B.B. Mohan Kumar Trading As East West Pharma & The Registrar of Trademarks
The Madras High Court dismissed the rectification petition filed by Sun Pharma Laboratories Ltd against Trademark No. 1764708. The court noted that the trademark in question had expired on December 17, 2018, and was not subsequently renewed. Consequently, the petitioner's request to remove the entry from the register became infructuous.
M.Sarojini v.M/s. Ce Biotech (P) Limited
The Madras High Court dismissed a petition filed by M.Sarojini seeking the expungement of the trademark ZIPROVIT (No. 1631278) from the register, which was held in the name of M/s. CE Biotech (P) Limited. The petitioner subsequently informed the court that they were withdrawing the petition due to the non-renewal of the relevant trademark registration. This outcome highlights the procedural necessity of maintaining active IP rights.
M/s. Medopharm / Medopharm Private Limited v.Leeford Healthcare Limited
The Madras High Court addressed a trademark infringement suit filed by Medopharm against Leeford Healthcare Limited regarding the use of 'EMICOF' versus the registered mark 'EMCOF'. The plaintiffs sought permanent injunctions and damages for alleged passing off and dilution. Ultimately, both parties reached an amicable resolution, which was formalized in a Memorandum of Compromise dated June 21, 2023. The court subsequently decreed the civil suit based on the terms of this compromise.
Merck KGa-A v.Tablets (India) Limited
Merck KGa-A filed a Civil Miscellaneous Appeal challenging the registration of a trademark application by Tablets (India) Limited. The appeal sought to set aside an earlier order and prevent the issuance of a Registration Certificate for Application No.887909 in Class 5. However, before any substantive arguments were heard, Merck KGa-A chose to withdraw its appeal. Consequently, the Madras High Court dismissed the case as withdrawn.
Sun Pharma Laboratories Limited v.Avighna Medicare Private Limited & Ors.
This Delhi High Court judgment confirms a comprehensive settlement between Sun Pharma Laboratories Limited (Plaintiff) and Avighna Medicare Private Limited & Ors. (Defendants). The parties resolved their trademark infringement dispute regarding the brands 'DOSELA' and 'ATENTRUE' versus 'DUZELA' and 'ATTENTROL'. Under the agreement, Defendant No. 1 agreed to cease all use of the infringing marks, destroy existing stock within specified timelines, and waive its own pending trademark applications for those names. The suit was subsequently disposed of based on these mutual undertakings.
Kilitch Drugs (India) Limited v.Zee Laboratories Limited
The Plaintiff, Kilitch Drugs, sought an interim injunction and relief for passing off against the Defendant, Zee Laboratories. The dispute centered on the alleged infringement of the Plaintiff's registered trademarks (KILITCH and KILITCH SRO) in pharmaceutical preparations by the use of the impugned mark KILITH/KILITH SRO.
Mankind Pharma Limited v.Shrinivas (Gujarat) Laboratories Pvt. Ltd.
Mankind Pharma Limited filed a suit against Shrinivas (Gujarat) Laboratories Pvt. Ltd., alleging that the latter was manufacturing and selling medicinal preparations under the deceptively similar trademark ZONFLOX, infringing on Mankind's registered trademark ZENFLOX. The court found the marks to be visually, phonetically, and structurally similar, leading to confusion among consumers.
Maharashtra Safe Chemists And Distributors Alliance Limited v.Sachin Bhausaheb Bhalekar & Anr.
The Bombay High Court dismissed a trademark infringement suit after noting that the disputed mark had already been removed from the register by the Registrar of Trademarks. The court accepted the defendant's affidavit stating that the trademark was never put into commercial operation, rendering all remaining claims for injunction and damages moot. This decision highlights how prior administrative actions (like rectification) can fundamentally alter the trajectory of a civil IP suit.
Maharashtra Safe Chemists And Distributors Alliance Limited v.Sachin Bhausaheb Bhalekar & Anr.
The Bombay High Court dismissed the suit filed by Maharashtra Safe Chemists And Distributors Alliance Limited against Sachin Bhausaheb Bhalekar and others. The court found that since the disputed trademark was successfully removed from the register via a rectification petition, and the defendant provided affidavits confirming no commercial use of the mark had ever occurred, all prayers in the original suit were rendered infructuous. This decision effectively closed the infringement proceedings.
M/s Martindal Research Laboratories v.M/s Shalina Laboratories Pvt Ltd
The Rajasthan High Court addressed a civil appeal concerning a trademark infringement dispute between Martindal Research Laboratories and Shalina Laboratories. The appellant sought to overturn an order that denied temporary injunction, citing lack of evidence regarding prior use of their mark 'VITAPLEX'. Recognizing the long pendency of the original suit (since 2008), the Court disposed of the appeal without interfering with the lower court's finding on interim relief. Instead, it directed the trial court to expedite the final decision on the merits of the case within a strict timeframe.
Vee Excel Drugs And Pharmaceuticals Pvt Ltd v.Hab Pharmaceuticals And Research Limited
The Delhi High Court dismissed an appeal filed by Vee Excel Drugs challenging the Intellectual Property Appellate Board's (IPAB) decision to cancel two pharmaceutical trademarks: 'VEGA ASIA' and 'VEGAH TABLETS'. The core issue revolved around determining prior use, particularly when one mark was registered on a 'proposed to be used basis.' The Court upheld the IPAB's finding that the subsequent user had the better right, emphasizing that the High Court should not re-appreciate evidence while exercising supervisory jurisdiction under Article 226.
Sun Pharmaceutical Industries Ltd. v.Vensat Bio & Ors.
In a significant ruling, the Delhi High Court allowed an application to set aside an ex parte judgment against Defendant No. 3 (Vensat Bio & Ors.) due to sufficient cause of absence. Simultaneously, the court recognized the strong prima facie case presented by Sun Pharmaceutical Industries Ltd., granting an interim injunction restraining the defendant from using deceptively similar marks like ORISON/SPORTEK in relation to pharmaceutical products. This dual outcome highlights the procedural complexities alongside the substantive strength of trademark infringement claims.
Hamdard National Foundation India v.Government Of Nct Delhi
Hamdard National Foundation India challenged the unrestricted use of 'Rogan Badam Shirin' by Ayurvedic manufacturers for almond oil, arguing it was reserved for Unani medicine. The petition sought directions to prevent unauthorized usage of this terminology. The court noted that the Ministry of Ayush had communicated to State licensing authorities that Raughan-E-Badam Shireen requires a Unani Drug License, thereby satisfying the petitioner's primary relief.
Datt Mediproducts Pvt Ltd v.Siddharth Mandal And Anr
The Delhi High Court ruled in favor of Datt Mediproducts Pvt Ltd regarding a petition seeking cancellation of a trademark registration. The court observed that the subject mark's registration had expired on March 5, 2022, and the mandatory renewal period, including the grace period, had lapsed without action by the respondent. Consequently, the court directed the concerned party to remove the non-renewed mark from the Register of Trade Marks.
Facing a trademark dispute?
Arctic's TM litigation team handles ~120 trademark matters per year across India, EU, and UK. From oppositions to infringement actions, we build winning arguments from precedent.